ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma
ContributorsFu, Maggie P
; Sharma, Mehul
; Yousefi, Pariya
; Merrill, Sarah M
; Tan, Ryan
; Samra, Simran
; Setiadi, Audi
; Golding, Liam
; Modi, Bhavi P
; Del Bel, Kate L
; Deyell, Rebecca J
; Rozmus, Jacob
; Rehmus, Wingfield
; Hildebrand, Kyla J
; James, Elliot
; Blanchard Rohner, Géraldine
; Lin, Susan
; Shopsowitz, Kevin E
; Terry, Jefferson
; Lee, Anna F
; Drögemöller, Britt I
; Matthews, Allison
; Tarailo-Graovac, Maja
; Sauvé, Laura
; Mitchell, Hana
; Prendiville, Julie S
; MacIsaac, Julia L
; Dever, Kristy
; Lin, David T S
; Meijer, Mandy
; Ross, Colin J D
; Dobson, Simon R M
; Vercauteren, Suzanne M
; Wasserman, Wyeth W
; van Karnebeek, Clara D M
; McKinnon, Margaret L
; Kobor, Michael S
; Turvey, Stuart E
; Biggs, Catherine M
Published inThe journal of experimental medicine, vol. 222, no. 10, e20240945
Publication date2025-10-06
First online date2025-07-31
Abstract
Keywords
- Humans
- DNA Methylation / genetics
- Epigenesis, Genetic
- Epstein-Barr Virus Infections / genetics
- Epstein-Barr Virus Infections / complications
- Herpesvirus 4, Human
- Immunologic Deficiency Syndromes / genetics
- Lymphoma / genetics
- Lymphoma / virology
- Repressor Proteins / deficiency
- Repressor Proteins / genetics
Affiliation entities
Research groups
Funding
- CIHR [EGM-141897]
- CIHR [PJT-178054]
- Genome British Columbia [SIP007]
- Michael Smith Health Research BC [HPI-2018-2041]
Citation (ISO format)
FU, Maggie P et al. ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma. In: The journal of experimental medicine, 2025, vol. 222, n° 10, p. e20240945. doi: 10.1084/jem.20240945
Main files (1)
Article (Published version)
Identifiers
- PID : unige:195545
- DOI : 10.1084/jem.20240945
- PMID : 40742536
Additional URL for this publicationhttps://rupress.org/jem/article-abstract/222/10/e20240945/278170/ASXL1-deficiency-causes-epigenetic-dysfunction
Journal ISSN0022-1007
